Abstract
A novel cytotoxic peptide, termed bisebromoamide (1), has been isolated from the marine cyanobacterium Lyngbya sp. Its planar structure was determined by 1D and 2D NMR spectroscopy. The absolute stereostructure of 1 was determined by chemical degradation followed by chiral HPLC analysis. Bisebromoamide (1) exhibited potent protein kinase inhibition: the phosphorylation of ERK in NRK cells by PDGF-stimulation was selectively inhibited by treatment with 10-0.1 microM of 1.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anticonvulsants / chemistry
-
Anticonvulsants / isolation & purification*
-
Anticonvulsants / pharmacology*
-
Cyanobacteria / chemistry*
-
Drug Screening Assays, Antitumor
-
Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
-
HeLa Cells
-
Humans
-
Lyngbya Toxins / chemistry
-
Lyngbya Toxins / isolation & purification*
-
Lyngbya Toxins / pharmacology*
-
Molecular Structure
-
Nuclear Magnetic Resonance, Biomolecular
-
Oligopeptides / chemistry
-
Oligopeptides / isolation & purification*
-
Oligopeptides / pharmacology*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / isolation & purification*
-
Protein Kinase Inhibitors / pharmacology*
Substances
-
Anticonvulsants
-
Lyngbya Toxins
-
Oligopeptides
-
Protein Kinase Inhibitors
-
bisebromoamide
-
Extracellular Signal-Regulated MAP Kinases